| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |